China National Medicines Corporation Ltd. (SHA:600511)
China · Delayed Price · Currency is CNY 27.34
-0.28 (-1.01%)
Oct 22, 2026, 3:00 PM CST
SHA:600511 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8,162 | 11,482 | 10,886 | 10,926 | 8,896 | 7,304 |
Trading Asset Securities | - | - | - | - | - | 11.4 |
Cash & Short-Term Investments | 8,162 | 11,482 | 10,886 | 10,926 | 8,896 | 7,316 |
Cash Growth | 5.63% | 5.47% | -0.36% | 22.81% | 21.60% | 17.53% |
Accounts Receivable | 17,986 | 14,743 | 13,931 | 12,881 | 12,550 | 13,392 |
Other Receivables | 331.76 | 186.45 | 199.01 | 204 | 389.69 | 79.93 |
Receivables | 18,317 | 14,929 | 14,130 | 13,085 | 12,940 | 13,472 |
Inventory | 5,397 | 5,192 | 4,956 | 3,961 | 3,717 | 3,515 |
Other Current Assets | 121.24 | 388.21 | 385.73 | 307.79 | 210.44 | 280.62 |
Total Current Assets | 31,997 | 31,991 | 30,357 | 28,279 | 25,764 | 24,584 |
Property, Plant & Equipment | 723.29 | 778.96 | 878.6 | 827.04 | 857.91 | 845.06 |
Long-Term Investments | 2,606 | 2,465 | 2,176 | 1,907 | 1,623 | 1,365 |
Goodwill | 203.77 | 203.77 | 203.77 | 203.77 | 203.77 | 203.77 |
Other Intangible Assets | 218.86 | 243.1 | 276.76 | 258.11 | 262.92 | 258.65 |
Long-Term Deferred Tax Assets | 179.72 | 163.25 | 149.07 | 123.87 | 124.37 | 115.94 |
Long-Term Deferred Charges | 100.27 | 148.78 | 152.39 | 150.06 | 86.19 | 89.6 |
Other Long-Term Assets | 784.04 | 690.6 | 734.85 | 703.57 | 686.95 | 548.08 |
Total Assets | 36,813 | 36,685 | 34,928 | 32,453 | 29,609 | 28,010 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 12,682 | 12,785 | 12,086 | 10,943 | 9,917 | 10,058 |
Accrued Expenses | 325.98 | 498.67 | 536.83 | 604.96 | 640.01 | 564.03 |
Short-Term Debt | 242.94 | 222.31 | 485.06 | 268.35 | 252.06 | 428.83 |
Current Portion of Leases | 89.55 | 102.11 | 100.2 | 74.08 | 80.5 | 75.81 |
Current Income Taxes Payable | - | 46.54 | 87.49 | 113.17 | 84.89 | 112.18 |
Current Unearned Revenue | 63.34 | 67.88 | 275.25 | 61.12 | 176.9 | 43.68 |
Other Current Liabilities | 1,229 | 1,680 | 1,285 | 1,830 | 1,589 | 1,457 |
Total Current Liabilities | 14,632 | 15,402 | 14,856 | 13,894 | 12,740 | 12,739 |
Long-Term Leases | 171.6 | 191.86 | 260.69 | 205.08 | 182.57 | 197.29 |
Long-Term Unearned Revenue | 24.43 | 34.18 | 38.79 | 46.06 | 46.35 | 42.66 |
Pension & Post-Retirement Benefits | 0.19 | 0.19 | 0.27 | 0.44 | 0.45 | 0.54 |
Long-Term Deferred Tax Liabilities | 14.51 | 17.8 | 24.19 | 26.78 | 33.47 | 35.39 |
Other Long-Term Liabilities | 826.37 | 730.63 | 773.55 | 747.14 | 747.14 | 639.8 |
Total Liabilities | 15,669 | 16,377 | 15,953 | 14,920 | 13,750 | 13,655 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 |
Additional Paid-In Capital | 2,349 | 2,349 | 2,349 | 2,349 | 2,349 | 2,349 |
Retained Earnings | 16,263 | 15,390 | 13,997 | 12,642 | 11,087 | 9,652 |
Comprehensive Income & Other | 41.85 | 50.92 | 27.28 | 30.74 | 24.04 | 24.91 |
Total Common Equity | 19,408 | 18,545 | 17,128 | 15,776 | 14,215 | 12,780 |
Minority Interest | 1,736 | 1,764 | 1,847 | 1,757 | 1,645 | 1,575 |
Shareholders' Equity | 21,144 | 20,308 | 18,975 | 17,533 | 15,859 | 14,355 |
Total Liabilities & Equity | 36,813 | 36,685 | 34,928 | 32,453 | 29,609 | 28,010 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 504.08 | 516.28 | 845.95 | 547.5 | 515.13 | 701.93 |
Net Cash (Debt) | 7,657 | 10,965 | 10,040 | 10,378 | 8,381 | 6,614 |
Net Cash Growth | 8.23% | 9.22% | -3.26% | 23.83% | 26.72% | 21.97% |
Net Cash Per Share | 10.15 | 14.53 | 13.31 | 13.76 | 11.11 | 8.77 |
Filing Date Shares Outstanding | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 |
Total Common Shares Outstanding | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 |
Working Capital | 17,365 | 16,589 | 15,501 | 14,385 | 13,025 | 11,845 |
Book Value Per Share | 25.72 | 24.58 | 22.70 | 20.91 | 18.84 | 16.94 |
Tangible Book Value | 18,986 | 18,098 | 16,648 | 15,314 | 13,748 | 12,318 |
Tangible Book Value Per Share | 25.16 | 23.99 | 22.06 | 20.30 | 18.22 | 16.33 |
Buildings | - | 408.84 | 408.84 | 408.84 | 433.49 | 387.18 |
Machinery | - | 830.63 | 802.66 | 759.8 | 702.78 | 661.15 |
Construction In Progress | - | - | 0.57 | 2.54 | 36.21 | 57.09 |